Fair Value Measurements

9 Months Ended

Mar. 31, 2020

Fair Value Disclosures [Abstract]

Fair Value Measurements

NOTE 7 - FAIR VALUE MEASUREMENTS

The carrying values of the Company’s financial instruments not required to be carried at fair value on a recurring basis approximate fair value due to their short maturities (i.e., accounts receivable, other assets, accounts payable and other liabilities and obligations for securities sold) or the nature and terms of the obligation (i.e., other notes payable and mortgage notes payable).

The assets measured at fair value on a recurring basis are as follows:

As of	3/31/2020		6/30/2019
Assets:	Total - Level 1		Total - Level 1
Investment in marketable securities:
REITs and real estate companies	$	1,671,000	$	3,069,000
Basic material		427,000		829,000
Corporate bonds		360,000		1,420,000
Consumer cyclical		105,000		1,448,000
Energy		101,000		950,000
Financial services		86,000		951,000
Technology		43,000		651,000
Healthcare		39,000		185,000
Industrials		21,000		193,000
	$	2,853,000	$	9,696,000

The fair values of investments in marketable securities are determined by the most recently traded price of each security at the balance sheet date.

Financial assets that are measured at fair value on a non-recurring basis and are not included in the tables above include “Other investments in non-marketable securities,” that were initially measured at cost and have been written down to fair value as a result of impairment. The following table shows the fair value hierarchy for these assets measured at fair value on a non-recurring basis as follows:

					Net loss for the nine months
Assets	Level 3		March 31, 2020		ended March 31, 2020
Other non-marketable investments	$	394,000	$	394,000	$	(103,000	)

						Net loss for the nine months
Assets		Level 3		June 30, 2019		ended March 31, 2019
Other non-marketable investments	$	612,000	$	612,000	$	(98,000	)

For the nine months ended March 31, 2020 and 2019, we received distribution from other non-marketable investments of $115,000 and $103,000, respectively.

Other investments in non-marketable securities are carried at cost net of any impairment loss. The Company has no significant influence or control over the entities that issue these investments and holds less than 20% ownership in each of the investments. These investments are reviewed on a periodic basis for other-than-temporary impairment. The Company reviews several factors to determine whether a loss is other-than-temporary. These factors include but are not limited to: (i) the length of time an investment is in an unrealized loss position, (ii) the extent to which fair value is less than cost, (iii) the financial condition and near term prospects of the issuer and (iv) our ability to hold the investment for a period of time sufficient to allow for any anticipated recovery in fair value.